Following Scandinavian ChemoTech's recent successes in Animal Care in the USA, the company is changing its strategy
After successfully establishing relationships with some of the larger veterinary groups within Animal Care in the USA, ChemoTech's management now chooses to leave the distributor strategy and intends to drive business development and clinical support in-house, which will also positively affect the company's margins.The strategy for ChemoTech's Animal Care operations in the USA and North America in the next few years will primarily be based on gradually growing with its own staff and with its own network of business developers together with the large groups with which the company has already